Search Within

TYPE 2 OBESITY
Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches

Journal: Current Pediatric Reviews
Volume: 12,Issue: 2
Page: 136-166
Authors: Merlin G. Butler, Ann M. Manzardo and Janice L. Forster

Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 36
Page: 5554-5557
Authors: Giovanna Muscogiuri, Stefano Palomba, Antonio Simone Laganà and Francesco Orio

Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment

Journal: Current Vascular Pharmacology
Volume: 13,Issue: 6
Page: 788-800
Authors: Georgios Daskalopoulos, Artemis Karkanaki, Athanasia Piouka, Nikolaos Prapas, Dimitrios Panidis, Paraschos Gkeleris and Vasilios G. Athyros

Polycystic Ovary Syndrome as a Proinflammatory State: The Role of Adipokines

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 36
Page: 5535-5546
Authors: Georgios K. Dimitriadis, Ioannis Kyrou and Harpal S. Randeva

Nonalcoholic fatty liver disease in children and adolescents – Relationship with Polycystic Ovary Syndrome

Journal: Current Pharmaceutical Design
Volume: 21,Issue: 35
Page: 5144-5150
Authors: Giselle Adriana Abruzzese and Alicia Beatriz Motta

Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular Risk

Journal: Current Vascular Pharmacology
Volume: 14,Issue: 5
Page: 415-425
Authors: Sarmad Said, Debabrata Mukherjee and Thomas F. Whayne

Adrenal Hyperandrogenism and Polycystic Ovary Syndrome

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 36
Page: 5588-5602
Authors: Manuel Luque-Ramírez and Héctor F. Escobar-Morreale

Metabolic Basis of Polycystic Ovarian Syndrome; Indications for Biochemical Screening

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 16,Issue: 1
Page: 61-71
Authors: Maxwell Omabe, Kenneth Nwobini Omabe, Famurewa Ademola Clement and Grace Maxwell Omabe

Approaches for the Development of Drugs for Treatment of Obesity and Metabolic Syndrome

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 7
Page: 895-903
Authors: Maksim L. Maksimov, Andrey A. Svistunov, Vadim V. Tarasov, Vladimir N. Chubarev, Marco Ávila-Rodriguez, George E. Barreto, Olga V. Dralova and Gjumrakch Aliev

Gut-Brain Axis and Metabolism in Polycystic Ovary Syndrome

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 36
Page: 5572-5587
Authors: Basak Ozgen Saydam and Bulent O. Yildiz

Editorial (Thematic Issue: Advances in the Diagnosis and Treatment of Polycystic Ovarian Syndrome)

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 36
Page: 5505-5507
Authors: Alicia Beatriz Motta

Cushing's Syndrome and Steroid Dementia

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 10,Issue: 1
Page: 50-55
Authors: Giampaolo Bernini and Domenico Tricò

Obesity and Body Fat Distribution as Predictors for Obstructive Sleep Apnea Syndrome

Journal: Current Respiratory Medicine Reviews
Volume: 11,Issue: 4
Page: 278-282
Authors: Stefan Mihaicuta, Izabela Anita Toth, Sorin Paralescu, Carmen Ardelean, Stefan Marian Frent and Oana Claudia Deleanu

Nature and Nurture in the Early-Life Origins of Metabolic Syndrome

Journal: Current Pharmaceutical Biotechnology
Volume: 17,Issue: 7
Page: 573-586
Authors: Antonio Gonzalez-Bulnes, Susana Astiz, Cristina Ovilo, Consolacion Garcia-Contreras and Marta Vazquez-Gomez

Adaptive Behavior in Williams-Beuren Syndrome, Down Syndrome, and Autism Spectrum Disorder

Journal: Current Psychiatry Reviews
Volume: 12,Issue: 3
Page: 226-239
Authors: Carolina G. Del Cole, Beatriz L. Araripe, Ivaldo Silva, Cristiane S. Paula, Sheila C. Caetano and Andrea P. Jackowski

Previous     Next

Go To   Results 1 - 15 of 6604